of the clinical manifestations of Borrelia burgdor:feri infection. Can J Infect Dis 1991;2(2):61-63. Lyme disease. cau sed by the s pirochete Borrelia burgdo1jeri, has class ically been divided into three stages: erythem a migrans; neurological or cardiac involvement; and a rthritis. Rather than defining a set disease pa ttern . however. one shou ld , more logically , conceptuali ze a progressive infection that m ay be localized or disseminated, acute or chronic. Erythema migrans. the earli est and most easily recognized manifestation of B burgdoljeri infection, is an expanding a nnular erythematous skin lesion with a central clearing that develops soo n after the bite of an infected ixodes tick. Musculoskeletal manifestations are common. with approximately one-h a lf of untreated individuals developing arthritis . Of these. only 10% have chronic arthritis. Invasion of the central nervous sys tem occ urs as th e infection disseminates hematogenously, with en cephalitis, myelitis and m eningopolyneuritis being the most severe results. Acute cardiac involvem ent is recognized in up to 8 % of adult patients. and less often in childre n . Early an tibiotic treatment of the infection is highly effective.
D AnwYLER AND LUFT

C LASSICALLY. LYME D ISEASE liAS BEEN DI VIDE D INTO
Lhree d istinct stages : ery th em a migra n s; n eurological or cardi ac in volvem ent: and a rthritis. Vi ewing th e diseas e in Lhis way insinua tes tha t organ system involve me nt proceeds in a fa irly orde r ly fa s hion . This is not Lh e cas e . Rather th a n con ce ptu a lizing Lyme d iseas e as a diseas e in wh ich organ syste m s become invo lved in a set pa tlern, on e s hould conceptua lize Borre lia burgd orjeri infec tion as a progressive infectiou s disease . In fecti on begins locally. with d issemination to multi ple organs and ti ssu es occurring early in th e co urse of infection in a h igh percentage of patients . It seems m or e logical. th erefore . to cons ider whether the infec tion in each of ils manifestations, is localized or clisseminalecl. acute or chronic .
OVERVIEW
Eryth ema migrans is Lhe earli est and m os t easily recognized m a nifesta tion of B burgdorje ri infection (1) . This ch a r acteris tic s kin lesion is observed in a pproxim ately two-thirds of palien ls, a nd u s ua lly develops a few clays Lo a few weeks following Lh e bile of a n infected ixocles Lick . Initia lly Lh e s piroch ete is localized Lo Lh e s kin lesion . a nd m ost individua ls a r e asymptoma ti c . As Lh e infecti on progresses, one or more sys tem ic s ign s or symptoms-fever. m a la ise, h eadach e. s tiff n eck . fa tigu e -develop , often he rald ing Lh e syste mi c s pread of this pathogen. The clearest evide nce of this early dissemina tion is the a ppearan ce of multiple a reas of eryth ema migra n s . with m ost seri es r eporting a n 8 to 15% inciden ce of multiple lesion s. The infectiou s loa d increa ses ra pidly in Lhis early phase . With acute h e ma togen ou s dissemina tion , maj or organ systems including Lh e h eart. bra in. liver a nd synovium may b ecome involved . Ac ute meningitis, me n in goen ceph a li tis, n europa thies . myocarditis with or without common b lock a bnorma lities. h epatitis . myos itis a nd . less commonly . fra nk a rthritis. are the mos t dra ma tic man ifestations of th e acu te clis semina lecl phase of infec tion .
As Lh e immune r esponse gains control of Lh e infection . th e number of s piroch e tes a ppears to drop a nd th e disease enters a more chronic phase . Although mul tiple organ sys tem s can be involved co n comita ntly, lo calized infla mma tory processes tend Lo predominate. Cons titutiona l s ign s a nd symptoms are gen era lly few . The s kin , n ervou s system and muscu loskeleta l system a re Lh e m aj or sys tems involved during Lh e chron ic phase.
DERMATOLOGICAL MANIFESTATIONS
Eryth em a migrans is class ically d escribed as a n expa nding annu la r eryth em a tou s s kin lesion wi th cen tr al clearing (1) . However , variations a re relatively common a nd include uniform ly erythem a-
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Lou s a nd targeL-lilce lesions . Erythema m igrans can be a s s ocia ted with m il d local pruritus, dysesthesia or m ild local d iscomfort (2) . Accompanying s ign s a nd symptoms can b e noted in about 40% of pa ti ents a t pres enta tion (l -3). S ign s and symptoms can b e qu ite diverse, ranging fro m m il d and tra n s itory symptoms to profound fa tigue, letha rgy, m il d en cepha lopathy , m en ingeal irr ita ti on . migra to ry muscu loskeletal pain, h epa t it is, gen era lized lympha denopa thy or splenomega ly , pharyngitis, pleurisy and myocarditis . Pa tien ts with n otable signs and symptoms proba bly h ave dissemination of th e pa thogen from th e local s ite. Erythema migrans clears s pontaneously within on e Lo four weeks in the overwhelmin g m ajority of untreated patients, and r ecurren ce is r a re.
MUSCULOSKELETAL MANIFESTATIONS
Muscul oskeleta l manifesta tions a re common (4). In acu te clissemina lecl infection, pain in joints. tendon s, bursas, muscle or bones is noted by Lh e maj ority of patients . True arthritis , usually involving la rge joints s u ch as th e knee, is ra rely noted. Ch a rac teristically only one or Lwo s it es a t a Lime a re affected , a nd symptoms la s t from a few hours Lo several clays.
In North America, a pproximately one-h a lf of unlrealecl individuals develop a rthritis as the infection progresses . This a rthritis , cha racter istica lly epis odic in n a ture, prima rily involves th e la rge j oints. The kn ee is the most commonly involved joint. Most series report a 90% or greater incide n ce of knee involvem en t. The a rthritis u s u a lly foll ows a benign course, with only 10% of pa tients developing chronic a rthritis . Even in such pati ents th ere tend to b e spontaneous remiss ions . S m a ll j oin t involvem ent is uncommon.
NERVOUS SYSTEM MANIFESTATIONS
Invasion of Lhe centra l n ervous system occ urs as B b w gdorfe ri disseminates h ematogenous ly ( 4). As reported by Steere e t a l (3), signs a nd symptom s refer able to th e n ervous system are common in pa ti en ts with erythe ma migrans . In tha t s tudy, 8 0% of a ll pa tients with erythema migrans experien ced ma la ise, fatigu e and lethargy; 64% experien ced h eadach es; and 48% experien ced n eck s tiffn es s (3).
Meningitis, cranial n euritis (most commonly seven Lh n erve) or pa inful ra d iculitis occurs in a pp roximately 15% of patients within th e firs t three m on th s of infection. Patients with a cra nial n europath y can have s ignificant cer ebrospinal fluid a bnorm a lities in t h e a bsen ce of obvious s ign s of meningitis; therefore, a lumbar puncture and exa mination of cerebros pinal fluid are r equired for a ppropria te eva luation of th es e patients or any patient suspected of having central nervous system involvement.
Chronic nervous system disease is more difficu lt to assess. Although there has recently been a great deal of speculation as to the fu ll range of neurological manifestations of the chronic phase of this infectious disease, it should be remembered that B burgdoTjeri causes unifocal or multifocal areas of inflammation in the brain and spinal cord, and that in the absence of objectively measurable abnormalities, the diagnosis should only be made with a great deal of caution, if at all.
Encephalitis, myelitis and meningopolyneuritis represent the most severe examples of nervous system involvement observed in disseminated B burgdoTj eri infection (5). More commonly, with sensitive neurophysiological techniques, 40% or more of patients with late disease are shown to have demonstrable abnormalities. The peripheral nervous system also has a wide spectrum of abnormalities, ranging from the severe, painful and debilitating meningopolyneuritis (Garin, Bujadoux, Bannwarth syndrome) to a milder but much more common neuropathy in patients with chronic inf~ction. Peripheral neuropathies may be distributed symmetrically or asymmetrically, and paresis of involved extremities can be associated with neuritis . Nerve conduction studies demonstrate that the abnormalities are secondary to axonal involvement and not demyelinization. Fatigue is noted by many patients with Lyme disease . However, fatigue in the absence of objectively measurable abnormalities is unlikely to be related to B burgdoTjeri infection , regardless of the serological status of the patient..
CARDIAC MANIFESTATIONS
Acute cardiac involvement, manifested by varying degrees of atrioventricular block, is recognized in up to 8% of adult patients , and less often in children (4) . Myocarditis or pericarditis is ob-served in approximately 65% of patients with card iac involvement. Although left ventricular dysfunction can be docu mented in a lmost 50% of these patients, it is usu a lly not clin ically significant. Late cardiac manifestations remain to be fully defined; there may be chronic carditis and cardiomyopathy.
TREATMENT
Few prospective randomized trials have been published. Still fewer have studied antibiotic regimens selected on the basis of the in vitro sensitivity of the organism. In a recent trial in patients with erythema migrans, both amoxicillin plus probenecid and doxycycline were demonstrated to be highly effective (6) . In contrast to earlier studies (7), none of the patients developed an obj ectively measurable abnormality post treatment, and none required retreatment. Other agents including oral cephalosporins and the new macrolide , azithromycin, are currently under study; however. the role these agents should play in the treatment of B burgdoTjeri infection remains to be defined.
Ceft.riaxone and penicillin have established roles in the treatment of disseminated infection (8, 9) . Ceftriaxone has been shown to be more effective than penicillin (8, 9) . Other third generation cephalosporins may also be efficacious. but they remain less well studied. Oral regimens have not been shown to provide adequate levels of antibiotic within the central nervous system and cannot be recommended when the nervous system is involved.
No published data demonstrate that prolonged antibiotic tl1erapy has any increased efficacy over conventional treatment regimens. Some patients with chronic disease ( 10 to 15%) appear to be refractory to antibiotic therapy and may have a post infectious immune-mediated disorder, the treatment of which has yet to be established.
